On 28 March 2022, Shanghai Pharmaceuticals Holding Co., Ltd. (600607.SH/02607.HK) (“SPH”) completed its non-public offering of A shares. The company raised RMB 13.975 billion in this non-public offering, with Yunnan Baiyao (000538.SZ) participating as a strategic investor, marking the refinancing project with the largest amount of funds raised by a listed company as well as the largest amount of funds raised by a listed company in A-share pharmaceutical industry so far.
On 1 April 2022, the application for non-public offering of A shares filed by Hengtong Logistics Co., Ltd. (603223.SH) (“Hengtong Logistics”) was passed and approved by the Listing Examination Committee of China Securities Regulatory Commission.
On 30 March 2022, the application filed by Zhejiang Tianzhen Bamboo Flooring Co., Ltd. (“Zhejiang Tianzhen”) for initial public offering and listing of shares on the ChiNext Market of Shenzhen Stock Exchange was reviewed and approved on the 17th meeting of the Listing Committee of ChiNext Market of Shenzhen Stock Exchange.
On 28 March 2022, Huaxin Cement Co., Ltd (600801.SH/06655.HK) (“Huaxin Cement”) was listed by way of introduction on the Main Board of the Hong Kong Stock Exchange, marking the first listed B-share company in Shanghai to switch to HK Stock Exchange by way of introduction.
On 16 March 2022, Shaanxi Sirui Advanced Materials Co., Ltd. (688102.SH) (“Shaanxi Sirui”) was successfully listed on the STAR Market of Shanghai Stock Exchange. The company issued 40.01 million shares and raised RMB 419 million in total. Grandall Xi’an Office acted as the legal counsel of the issuer.
On 3 March 2022, the application filed by Guobo Electronics Co., Ltd. (“Guobo Electronics”) for initial public offering and listing on the STAR Market of Shanghai Stock Exchange was passed and approved by the Listing Committee of the STAR Market at the 14th meeting in 2022.
On 14 February 2022, the application filed by Guangdong Senssun Weighing Apparatus Group Ltd. (002870.SZ.) (“Senssun”) for non-public offering was passed and approved by the Issuance Examination Committee of China Securities Regulatory Commission.
On 16 February 2022, Guangdong Yuehai Feeds Group Co., Ltd. (001313.SZ.) (“Yuehai”) successfully listed on the mainboard of Shenzhen Stock Exchange, and Grandall Shenzhen Office acted as the legal advisor.
On 3 November 2021, the application filed by Canature Health Technology Group Co., Ltd. (“Canature”, 300272.SZ) for registering its issue of shares to specific target was passed and approved by China Securities Regulatory Commission.
On 4 January 2022, the application filed by Shanghai Huaming Power Equipment Co., Ltd. (“Shanghai Huaming”, 002270.SZ) for its non-public offering of A-shares was passed and approved by China Securities Regulatory Commission.
The year 2021 has witnessed Grandall's leading position in IPO practice area, continuously leading the capital markets legal service industry. According to the statistics of China Securities Regulatory Commission, Shanghai Stock Exchange, Shenzhen Stock Exchange and Beijing Stock Exchange, there were a total of 522 companies which completed their initial public offerings and listings in 2021; among them, 75 were served by Grandall as issuer legal advisor, representing 14.4% of the total, ranking first among law firms. Meanwhile, among the 443 companies which were approved for their initial public offerings in 2021, a total of 54, or 12.2%, were served by Grandall as issuer legal advisor, ranking first among law firms.
